Ginkgo Bioworks Holdings Inc (DNA) stock is down -63.96% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives DNA stock a score of 35 out of a possible 100.

That rank is mainly influenced by a short-term technical score of 1. DNA’s rank also includes a long-term technical score of 10.

DNA has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on DNA!

See Full DNA Report

Ginkgo Bioworks Holdings Inc (DNA) stock has risen 2.14% while the S&P 500 is down -0.31% as of 11:13 AM on Tuesday, Jan 17. DNA is higher by $0.04 from the previous closing price of $1.87 on volume of 8,139,850 shares. Over the past year the S&P 500 has fallen -12.90% while DNA is down -63.96%. DNA lost -$2.23 per share in the over the last 12 months. Click Here to get the full Stock Report for Ginkgo Bioworks Holdings Inc stock.